In a report issued on November 9, Jeffrey Zekauskas from J.P. Morgan maintained a Hold rating on Minerals Technologies (MTX – Research Report), with a price target of $80.00. The company’s shares closed last Wednesday at $73.84.
According to TipRanks.com, Zekauskas is a 5-star analyst with an average return of 9.9% and a 68.4% success rate. Zekauskas covers the Basic Materials sector, focusing on stocks such as Air Products and Chemicals, Sherwin-Williams Company, and Axalta Coating Systems.
The word on The Street in general, suggests a Hold analyst consensus rating for Minerals Technologies with a $80.00 average price target.
Minerals Technologies’ market cap is currently $2.46B and has a P/E ratio of 16.80. The company has a Price to Book ratio of 7.38.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Minerals Technologies, Inc. develops, produces, and markets specialty mineral, mineral-based, and synthetic mineral products. It operates through the following four segments: Performance Materials, Specialty Minerals, Refractories and Energy Services. The Performance Materials segment supplies bentonite and bentonite-related products, chromite and leonardite. The Specialty Minerals segment produces and sells the synthetic mineral product precipitated calcium carbonate and processed mineral product quicklime, and mines mineral ores then processes and sells natural mineral products, primarily limestone and talc. The Refractories segment produces monolithic and shaped refractory materials and specialty products, also provides services and sells application and measurement equipment, and calcium metal and metallurgical wire products. The Energy Services segment provides services to improve the production, costs, compliance, and environmental impact of activities performed in oil and gas industry. The company was founded on February 19, 1968 and is headquartered in New York, NY.
Read More on MTX:
- J.P. Morgan Maintains a Hold Rating on Envestnet (ENV)
- J.P. Morgan Reaffirms Their Hold Rating on Nevro Crop (NVRO)
- Beam Therapeutics (BEAM) Receives a Hold from J.P. Morgan
- JonesTrading Thinks T2 Biosystems’ Stock is Going to Recover
- Adaptimmune Therapeutics (ADAP) Gets a Buy Rating from JonesTrading